BACKGROUND: Mitochondrial dysfunction plays a role in the development of muscle insulin resistance (IR) and the accumulation of intramyocellular lipid (IMCL) in skeletal muscle that can, in turn, interfere with insulin signaling. The purpose of this study was to assess mitochondrial function (MF) and IMCL in obese adolescent girls with and without IR to determine whether: (1) Girls with IR have impaired MF, and (2) impaired MF in girls with IR is related to higher IMCL. METHODS: We examined 22 obese girls aged 13-21 years old for IR [defined as a homeostasis model assessment of insulin resistance (HOMA-IR) value >4. Phosphorus magnetic resonance spectroscopy (31P-MRS) and proton magnetic resonance spectroscopy (1H-MRS), respectively, were used to determine MF and IMCL of the soleus muscle along with magnetic resonance imaging (MRI) measures of visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) in girls with HOMA-IR >4 (insulin-resistant group) versus HOMA-IR ≤ 4 (insulin-sensitive group). Serum lipids and waist-to-hip ratio (W/H) were also measured. RESULTS: Girls with IR (n=8) did not differ from the insulin-sensitive group (n=14) for age, bone age, weight, VAT, SAT, TAT, or IMCL. However, the insulin-resistant group had higher W/H. Additionally the insulin-resistance group had a lower log rate of postexercise phosphocreatine (PCr) recovery (ViPCr) and a higher log PCr recovery constant (tau), indicative of impaired MF. CONCLUSIONS: Obese girls with increased IR have impaired mitochondrial function. This association is not mediated by alterations in IMCL or adipose tissue. Further studies are necessary to determine whether there is a causal relation between impaired mitochondrial function and IR in obesity and mediators of such a relationship.
BACKGROUND:Mitochondrial dysfunction plays a role in the development of muscle insulin resistance (IR) and the accumulation of intramyocellular lipid (IMCL) in skeletal muscle that can, in turn, interfere with insulin signaling. The purpose of this study was to assess mitochondrial function (MF) and IMCL in obese adolescent girls with and without IR to determine whether: (1) Girls with IR have impaired MF, and (2) impaired MF in girls with IR is related to higher IMCL. METHODS: We examined 22 obesegirls aged 13-21 years old for IR [defined as a homeostasis model assessment of insulin resistance (HOMA-IR) value >4. Phosphorus magnetic resonance spectroscopy (31P-MRS) and proton magnetic resonance spectroscopy (1H-MRS), respectively, were used to determine MF and IMCL of the soleus muscle along with magnetic resonance imaging (MRI) measures of visceral, subcutaneous, and total adipose tissue (VAT, SAT, and TAT) in girls with HOMA-IR >4 (insulin-resistant group) versus HOMA-IR ≤ 4 (insulin-sensitive group). Serum lipids and waist-to-hip ratio (W/H) were also measured. RESULTS:Girls with IR (n=8) did not differ from the insulin-sensitive group (n=14) for age, bone age, weight, VAT, SAT, TAT, or IMCL. However, the insulin-resistant group had higher W/H. Additionally the insulin-resistance group had a lower log rate of postexercise phosphocreatine (PCr) recovery (ViPCr) and a higher log PCr recovery constant (tau), indicative of impaired MF. CONCLUSIONS:Obesegirls with increased IR have impaired mitochondrial function. This association is not mediated by alterations in IMCL or adipose tissue. Further studies are necessary to determine whether there is a causal relation between impaired mitochondrial function and IR in obesity and mediators of such a relationship.
Authors: M Brochu; R D Starling; A Tchernof; D E Matthews; E Garcia-Rubi; E T Poehlman Journal: J Clin Endocrinol Metab Date: 2000-07 Impact factor: 5.958
Authors: Vera B Schrauwen-Hinderling; Matthijs K C Hesselink; Patrick Schrauwen; Marianne Eline Kooi Journal: Obesity (Silver Spring) Date: 2006-03 Impact factor: 5.002
Authors: R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson Journal: Adv Data Date: 2000-06-08
Authors: V B Schrauwen-Hinderling; M E Kooi; M K C Hesselink; J A L Jeneson; W H Backes; C J A van Echteld; J M A van Engelshoven; M Mensink; P Schrauwen Journal: Diabetologia Date: 2006-11-09 Impact factor: 10.122
Authors: G Á Martos-Moreno; A Mastrangelo; V Barrios; A García; J A Chowen; F J Rupérez; C Barbas; J Argente Journal: Int J Obes (Lond) Date: 2017-06-07 Impact factor: 5.095
Authors: Melanie Cree-Green; Ninghe Cai; Laura Pyle; Brandy Ringham; Mark S Brown; Bradley R Newcomer; Kristen J Nadeau; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2017-05-01 Impact factor: 5.958
Authors: Estelle Heyne; Andrea Schrepper; Torsten Doenst; Christina Schenkl; Katrin Kreuzer; Michael Schwarzer Journal: J Cell Mol Med Date: 2020-05-04 Impact factor: 5.310
Authors: Melissa M Thomas; Karin E Trajcevski; Samantha K Coleman; Maggie Jiang; Joseph Di Michele; Hayley M O'Neill; James S Lally; Gregory R Steinberg; Thomas J Hawke Journal: Physiol Rep Date: 2014-09-17